StockNews.com initiated coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a research note released on Thursday morning. The brokerage issued a sell rating on the stock.
Separately, HC Wainwright lifted their price target on SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a research note on Thursday, December 12th.
Check Out Our Latest Analysis on SenesTech
SenesTech Trading Down 4.7 %
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Read More
- Five stocks we like better than SenesTech
- What is the Dow Jones Industrial Average (DJIA)?
- Jabil’s Winning Streak Begins: Market Bottom Set, Future in Focus
- Consumer Staples Stocks, Explained
- High-Flying HEICO Eyes New Heights in 2025
- What Are the U.K. Market Holidays? How to Invest and Trade
- Beyond Reality: Investing in AR/VR Tech for Future Gains
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.